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A novel nanozyme assay utilising the catalytic activity of silver 
nanoparticles and SERRS 
S. Sloan-Dennison a, S. Laing a, N. Shand b, D. Graham a and K. Faulds a   
Artificial enzymes have become an increasingly interesting area of research due to their many 
advantages over natural protein enzymes which are expensive, difficult to isolate and unable to 
stand harsh environments. An important area of this research involves using metal nanoparticles 
as artificial enzymes, known as nanozymes, which exhibit peroxidase-like activity enabling them to 
ĐĂƚĂůǇƐĞƚŚĞŽǆŝĚĂƚŝŽŶŽĨƐƵďƐƚƌĂƚĞƐƐƵĐŚĂƐ ? ? ? ? ? ? ? ? ?-tetramethylbenzidine (TMB) in the presence 
of hydrogen peroxide (H2O2), giving a colorimetric response. Here we exploit the catalytic activity 
of silver nanoparticles (Ag NPs) in a surface based silver-linked immunosorbent assay (SLISA) to 
detect human C-reactive protein (CRP), an inflammatory marker.  Ag NPs were conjugated to 
antibodies with specific recognition for the corresponding target antigenic molecule, CRP, and the 
Ag NPs were used to catalyse the oxidation of TMB by H2O2.  The resulting coloured oxidation 
product was detected using SERRS. We demonstrate that Ag NPs can replace the enzymes used in 
a conventional ELISA and a detection limit of 1.09 ng/mL of CRP can be achieved.  It indicates the 
promise for SLISAs for biomarker detection and opens the way for further assays of this nature to 
be created.   This novel assay has the potential to be optimised to detect lower levels of CRP and 
can be further extended for the sensitive and specific detection of other relevant biomarkers. 
Introduction 
C-reactive protein (CRP) is a pentameric protein which is found in 
blood plasma and is a systemic marker of inflammation and tissue 
damage.1  Although it is considered a non-specific biomarker, 
research has suggested that patients with an elevated base level of 
CRP are at a higher risk of diabetes,2 sepsis,3 and most importantly, 
cardiovascular disease.4  Thus, monitoring CRP levels is considered a 
useful method of screening and disease management. CRP is 
conventionally detected using an enzyme-linked immunosorbent 
assay (ELISA), which is a commonly employed clinical method for the 
detection and quantification of biomarkers.  Sandwich ELISAs utilise 
a monoclonal antibody immobilised on a solid substrate with 
specificity for a distinct antigen.  Following the specific antibody-
antigen interaction, a secondary antibody can be added, which is 
functionalised with an enzyme.5 The enzyme activity can 
subsequently be measured by means of its reaction with a 
chromogenic substrate, such as  ? ? ? ? ? ? ? ? ?-tetramethylbenzidine 
(TMB), which is oxidised to a blue charge transfer complex (CTC).  
This then generates a detectable colorimetric signal which is 
proportional to the amount of analyte present. Therefore, by  
measuring the intensity of the blue colour of the CTC using UV-vis 
spectroscopy, the concentration of target can be determined.  
Resonance Raman spectroscopy (RRS) has also been utilised in 
combination with TMB for detection in a standard ELISA by using a 
Raman excitation wavelength in resonance with the absorbance 
maxima of the CTC.6 In this approach, it was demonstrated that by 
using RRS in place of the traditional colorimetric detection method, 
a 50 times lower detection limit of antigen  (TNF-ɲ ?ǁĂƐĂĐŚŝĞǀĞĚ ?
This method was also extended to a surface-based assay for the 
detection of prostate-specific antigen (PSA) with a detection limit of 
60 ng/mL. 7 
To further increase the sensitivity, nanoparticles (NPs) have also 
been incorporated into ELISAs.  Merkoci et. al. first demonstrated the 
use of gold (Au) NPs as carriers of signalling antibody, functionalised 
with the enzyme horseradish peroxidase (HRP), in order to achieve 
amplification of the signal.8  Since the Au NPs allow more HRP to be 
present per antigen-antibody interaction, more HRP-mediated TMB 
oxidation can take place.  Therefore, when analysed using UV-vis 
a. Centre for Molecular Nanometrology, Technology and Innovation 
Centre, University of Strathclyde, 99 George Street, Glasgow, UK 
b. DSTL, Porton Down, Salisbury UK,  
 
Electronic Supplementary Information (ESI) available: [details of any supplementary 
information available should be included here]. See DOI: 10.1039/x0xx00000x 
ARTICLE Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
 
 
spectroscopy, an enhanced oxidation signal was obtained.  Another 
benefit of using NPs in ELISAs is the ability to utilise their roughened 
metal surface by adsorbing colorimetric probes onto them and 
analysing using surface enhanced resonance Raman scattering 
(SERRS) which was first reported by Campbell et al.9 When the ELISA 
substrate bromochloroindolylphosphate (BCIP), was added to the 
sandwich ELISA with an antibody conjugated to alkaline phosphate, 
a blue dimeric species was produced which could be adsorbed onto 
Au NPs and a strong SERRS signal was achieved and correlated to the 
concentration of CRP.  Graham et. al. also reported the use of SERRS 
as a readout technique in an ELISA by using the commercially 
ĂǀĂŝůĂďůĞ ƉĞƌŽǆŝĚĂƐĞ ƐƵďƐƚƌĂƚĞ  ? ? ? ?- azino-bis (3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS), as the enzyme-
transformable chromogen.10 Detection antibody functionalised with 
HRP was used to oxidise the ABTS and upon the addition of Au NPs, 
the oxidised ABTS was adsorbed onto the surface. SERRS analysis 
could take place by interrogating the solution using a laser with an 
excitation wavelength close to the absorbance maximum of the 
oxidised ABTS product and could detect pg/mL detection of prostate 
specific antigen. More recently silver (Ag NPs) have been used to 
increase the signals obtained from an ELISA.  Zhan et al. reported the 
electrostatic attraction of negatively charged citrate capped Ag NP to 
the positively charged oxidised TMB product of an ELISA.11  
Aggregation of the Ag NP was also induced, producing highly 
enhanced Raman scattering which could be related to the 
concentration of respiratory syncytial, resulting in pg/mL detection. 
All of these ELISAs used detection antibodies conjugated to HRP due 
to its effectiveness in catalysing the oxidation of TMB.  However, its 
enzymatic activity gradually decreases with its long term storage and 
the isolation of HRP is time consuming and expensive.12  Therefore, 
there has been a significant interest into the investigation of NPs as 
artificial enzymes, known as nanozymes, due to their cheap and easy 
synthesis, long term storage, robustness in a variety of environments 
and size/composition dependent activity which could address the 
disadvantages of natural enzymes.13 
Recently, it has been found that many metal NPs possess an intrinsic 
enzyme mimetic activity. The first example of this activity was 
reported by Gao et. al.14 in 2007, who showed that ferromagnetic 
nanoparticles (MNPs) exhibit is catalytic activity and can catalyse the 
oxidation of TMB in the presence of hydrogen peroxide (H2O2).  The 
catalytic activity of MNPs was also developed into a capture-
detection sandwich immunoassay format for a simple colorimetric 
assay, to detect the presence and concentration of rotavirus by 
measuring the intensity of the blue CTC produced by the MNPs.15  
This intrinsic enzyme mimetic activity is not restricted to MNPs and 
there has been a recent rise in publications describing a variety of 
metal NPs with catalytic activity, including ceria,16 Au 17 and Ag NPs,18 
all of which have been used for the detection of glucose and/or H2O2.  
Furthermore, many research groups have investigated and adopted 
the classic sandwich immunoassay format for detection using many 
different peroxidase mimicking nanozymes.  For example, Kim et. al. 
utilised the highly active peroxidase mimics, MNPs and platinum NPs, 
within porous carbon, as a signalling element for labelling with 
antibodies for the detection of human epidermal growth factor with 
a detection limit as low as 1.5 ng/mL when analysed using UV-vis 
spectroscopy. 19 The catalytic activity of Au NPs conjugated to 
antibodies has also been applied in an ELISA format.  However, Wang 
et al. reported that the catalytic activity was inhibited due to the 
addition of the protein molecules, but could be increased by the 
deposition of Au due to the formation of a new Au shell.  When 
added, TMB was oxidised producing a bright blue colour and a naked 
eye limit of detection (LOD) of 5 ng/mL of human immunoglobulin 
(IgG) was achieved.  The catalytic activity of Au NP conjugated to 
antibodies has also been increased by combining them with carbon 
nanotubes, and the resulting nanohybrid displayed enhanced 
catalytic activity.20   
The enzyme mimicking activity of Ag NPs has also been 
demonstrated to catalyse the oxidation of TMB with H2O2.  However, 
unlike other nanozymes, the oxidised CTC product can be detected 
not only by UV-vis spectroscopy but also by SERRS. Recently we have 
shown that the catalytic activity of Ag NPs can be used to provide a 
novel method of analysis for the detection of H2O2.18  The Ag NPs 
catalyse the oxidation of TMB to the resulting positively charged CTC, 
which was adsorbed onto the surface of the Ag NPs resulting in a 
SERRS response.  This approach of applying SERRS for the detection 
of the nanozyme-catalysed oxidation product resulted in the fast, 
direct detection of H2O2 with a detection limit of 100 nM.18 
 
 
In the work reported here, we investigate the combination of an 
ELISA with the novel concept of utilising the peroxidase properties of 
TMB
H2O2
Capture Ab
SERRS
signal
CRP                                        Ag-Ab NPs
Fig.1 Schematic of SERRS detection of CRP using a SLISA. Capture 
antibodies were immobilised onto the surface of a nitrocellulose 
coated glass slide, followed by incubation with CRP and silver 
nanoparticles functionalised with antibody (Ag-ďEW ?Ɛ ? ?dDĂŶĚ
H2O2 ǁĞƌĞ ƚŚĞŶ ĂĚĚĞĚ ĂŶĚ ƚŚĞ Ő EW ?Ɛ ĐĂƚĂůǇƐĞ ƚŚĞ ŽǆŝĚĂƚŝŽŶ ŽĨ
TMB to the CTC, which can then be detected using SERRS. 
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Ag NPs, enabling the sensitive detection using SERRS, without 
increasing the complexity of the procedure in this first in class 
immunoassay. We demonstrate the application of Ag NPs conjugated 
to antibodies, which can replace conventional enzymes such as HRP, 
therefore the Ag NPs acts as an enzyme mimic,  for the detection of 
CRP, creating a silver-linked immunosorbent assay (SLISA) shown in 
Figure 1.  By introducing Ag NPs into the assay, the TMB is oxidised 
without the need of an enzyme conjugated to an antibody, therefore 
reducing the cost of the assay.  The coloured oxidised TMB product 
can also be analysed using SERRS and a lower detection limit of CRP 
can be achieved.   
Experimental  
Materials 
Silver nitrate, sodium citrate,  ? ? ? ? ? ? ? ? ?-tetramethylbenzidine (TMB), 
hydrogen peroxide, Tween 20® and phosphate-buffered saline (PBS) 
tablets were all purchased from Sigma Aldrich, UK. TMB blotting 
solution was purchased from Thermo Fisher Scientific, UK. An ELISA 
test kit comprising of capture antibody and CRP standard was 
purchased from R&D systems, UK, PATH® protein microarray slides 
were purchased from GRACE bio-labs, USA and SeraSub was 
purchased from CST Technologies, USA. 
Instrumentation 
Extinction measurements were all carried out using a Cary 300 Bio 
UV-vis spectrometer.  Particle size and zeta measurements were 
obtained using a Malvern Zetasizer Nano series.  Solution spectra 
were collected using a Snowy Range Sierra series reader with a 
638 nm excitation wavelength with a 4.5 mW laser power. Raman 
spectra from nitrocellulose surfaces were collected using a Renishaw 
InVia microscope with a 633 nm excitation wavelength with 0.8 mW 
laser power. The solution measurements were used to optimise the 
NP functionalisation conditions and the 633 nm microscope system 
was used for detection in the final assay. 
Silver nanoparticle synthesis and characterisation 
All glassware was soaked in aqua regia (HCl, HNO3 3:1 v/v) for 1-2 
hours before use.  500 mL of distilled water was heated to 45 oC in a 
3 necked round bottom flask.  90 mg of silver nitrate (dissolved in 
10 mL of distilled water) was then added and the solution heated 
until boiling.  A 10 mL solution of 1% sodium citrate was then added 
and boiling maintained for 90 minutes.  Constant stirring was 
maintained throughout using a glass linked stirrer.  The synthesised 
Ag NPs were characterised using extinction spectroscopy to obtain 
the maximum absorbance by diluting 50 µL in 450 µL of distilled 
water.  The concentration of the Ag NPs could then be calculated 
using the Beer-Lambert law and a molar extinction coefficient of  
 
1.04x1010 M-1 cm.21 Size and zeta measurements were obtained by 
analysing 1 mL of the colloidal nanoparticles on a Malvern Zetasizer. 
(See supplementary information Figure 1). 
Catalytic activity of Ag NPs 
100 µL of Ag NPs (0.8 nM) was added to 100 µL of TMB (3 mM), 
100 µL of H2O2 (6 mM) and 200 µL distilled water and analysed using 
extinction spectroscopy by taking 50 µL of the sample and diluting it 
in 450 µL distilled water and with Raman spectroscopy, with no 
dilution, using a 638 nm laser excitation at 40 mW and a 1 second 
accumulation time.  Control samples were carried out by omitting 
one of the components of the assay and were also analysed in the 
same manner, replacing the omitted components with distilled 
water in each case.  Samples were prepared in triplicate and 5 scans 
of each were obtained.   
Functionalisation of Ag-Ab NP conjugates 
Final concentrations of mouse anti-human CRP antibody (2.5, 1, 0.5, 
 ? ? ? ? ? ? ? ? ?ĂŶĚ ?ʅŐ ?ŵ> ?ǁĞƌĞĂĚĚĞĚƚŽ ? mL of Ag NPs with a pH of 
7.9 and left to shake overnight. The solutions were then centrifuged, 
the supernatant removed and the NPs resuspended in 500 uL of 
distilled water.  Ag-Ab NPs were then characterised using extinction 
spectroscopy and dynamic light scattering (DLS) (See supplementary 
information Figure 2 (a) and (b)). 
Catalytic activity of Ag-Ab NPs 
100 µL of Ag-Ab NPs conjugate was added to 100 µL of TMB (3 mM), 
100 µL of H2O2 (6 mM) and 200 µL of distilled water and analysed 
with a 638 nm laser excitation at 40 mW and a 1 second accumulation 
time.  Samples were prepared in triplicate and 5 scans of each were 
obtained.   
Silver-linked immunosorbent assay (SLISA) 
0.3 µL of mouse anti-human CRP antibody (10 µg/mL) was spotted 
onto a nitrocellulose coated glass slide and left to incubate overnight 
at room temperature.  The slide was then washed three times with 
wash buffer (0.05% Tween 20® in PBS buffer (pH 7.4)) and 20 µL of 
human CRP (various concentrations) was then added and left to 
incubate for 20 minutes, followed by three wash steps with wash 
buffer.  20 µL of Ag-Ab NP conjugates was then added to the slide 
and left to incubate for 15 minutes before washing again. 20 µL of 
TMB blotting solution was then added and removed after 20 minutes 
followed by a final wash step with wash buffer. 
SLISA controls were also performed using 25 ng/mL of bovine serum 
albumin (BSA) and Human chronic gonadotropin (hCG). The SLISA 
was also carried out using 1% seraSub spiked with 100 ng/mL CRP.   
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SERRS analysis 
The SLISA was analysed as follows: each SLISA spot (with different 
concentrations of CRP) was interrogated at 100 different random 
points using a 633 nm laser excitation with a 9 second accumulation 
time and 0.8 mW laser power.  The spectra were then baseline 
corrected using intelligent fitting on WiRE 4.2 software and the 
overall spot average was obtained using Matlab 
Results and discussion 
As shown in Figure 1, detection antibodies functionalised with 
enzymes that are used in traditional ELISAs can be replaced with 
citrate capped Ag NPs functionalised with antibody, to form a SLISA. 
When capture antibody and CRP are immobilised onto a solid 
substrate, Ag NPs conjugated to antibodies can specifically bind to 
the immobilised CRP forming the SLISA spot. Once TMB is added, the 
Ag NPs catalyse the oxidation with H2O2 and the oxidised TMB can be 
detected using SERRS.  The intensity of the oxidised TMB signal can 
therefore be related to the concentration of Ag NPs, which can be 
correlated to the amount of CRP present. 
Catalytic activity of Ag NPs  
The oxidation of TMB by Ag NPs and H2O2 occurs via the two-step 
two-electron oxidation shown in Figure 2.  The first one-electron 
oxidation produces a radical cation with an absorbance maximum at 
370 nm, which exists in equilibrium with the blue CTC which has an 
absorbance maximum at 650 nm.  The addition of a strong inorganic 
acid then terminates the reaction yielding the yellow TMB2+ with an 
absorbance maximum at 450 nm. 22  
To demonstrate the oxidation of TMB via the catalytic activity of Ag 
NPs, Ag NPs (0.8 nM) were added to TMB (3 mM) and H2O2 (6 mM) 
and the extinction spectrum (along with spectra from control 
experiments) are shown in Figure 3 (a). The oxidation of the TMB is 
clearly visible by the appearance of the absorption maximum of the 
CTC at 650 nm when TMB and H2O2 were added.  This peak does not 
appear in any of the control experiments confirming the catalytic 
activity of Ag NPs.  Aggregation also occurred when all three 
components were added due to the positive CTC molecule being 
formed, which is electrostatically attracted to the negative NP 
surface, effectively pulling multiple NPs together.  
Parent Diamine
(TMB0)
Radical cation
(TMB+)ɉmax=370 nm 
Charge transfer complex
(CTC)ɉmax=650 nm 
-e-
-e-
Diimne oxidation product
(TMB2+)ɉmax=450 nm 
Fig.2 Oxidation of TMB by H2O2 in the presence of Ag NPs to its first 
oxidation step (TMB+),  which exists in equilibrium with the charge 
transfer complex (CTC), and to the second oxidation step (TMB2+) 
with the addition of an acid. 
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Fig. 3 (a) Normalised extinction spectra and (b) SERRS response of H2O2 (green), TMB (dark blue), Ag NPs (black), Ag NPs and H2O2 (red), Ag NPs 
and TMB (light blue) and Ag NPs, TMB and H2O2 (pink).  Extinction spectra were normalised to 1 for clarity and SERRS spectra were obtained using 
a 638 nm laser excitation with a 1 second accumulation time and 4.5 mW laser power.  The spectra shown are the average of 5 measurements 
of 3 replicate samples 
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The SERRS results obtained, shown in Figure 3 (b), confirmed that 
TMB is only oxidised to the CTC in the presence Ag NPs and H2O2.  The 
spectrum shows the three main characteristic peaks of the CTC, 1191 
cm-1, 1336 cm-1 and 1610 cm-1, which represent CH3 bending modes, 
inter-ring C-C stretching modes and a combination of ring-stretching 
and CH bending modes, respectively.18 A small CTC signal occurs 
when just TMB is added to the Ag NPs due to H+ ions on the surface 
of the NP causing some oxidation of the TMB. 
The catalytic activity of the Ag NPs is proposed to be attributed to 
the adsorption of H2O2 on the surface of Ag NPs, causing it to break 
into OH radicals as the Ag NP surface is oxidised from Ag0 to Ag+.  The 
free radicals then proceed to cause the oxidation of the TMB to the 
CTC, forming H2O in the process.23  Therefore, as the catalytic activity 
is dependent on the initial adsorption of H2O2, the catalytic activity of 
Ag NPs is high due to its un-functionalised citrate capped surface.  
For this reason, it was unknown whether Ag NPs functionalised with 
antibodies would exhibit the same catalytic property since a large 
portion of the Ag NP surface will no longer be available, which could 
adversely affect the oxidation of TMB by the metal surface.   
To investigate the effect of surface modification on the catalytic 
activity, Ag NPs were functionalised with mouse anti-human CRP 
ĂŶƚŝďŽĚǇ ? &ŝŶĂůĐŽŶĐĞŶƚƌĂƚŝŽŶƐŽĨ  ? ? ? ?  ? ?  ? ? ? ?  ? ? ? ?ĂŶĚ  ? ? ? ?ʅŐ ?ŵ>
were added to the Ag NPs via a pH correction method.  By altering 
the pH of the antibodies to lower than their amine pKa, the 
antibodies became positively charged and could therefore 
electrostatically bind to the negative Ag NP surface, creating Ag-Ab 
NP conjugates.  3 mM TMB and 6 mM H2O2 were added to the Ag-Ab 
NP conjugates and then analysed using 638 nm laser excitation to 
assess the catalytic activity.   
tŚĞŶŚŝŐŚĐŽŶĐĞŶƚƌĂƚŝŽŶƐŽĨĂŶƚŝďŽĚǇ ? ? ? ?ʅŐ ?ŵ>ĂŶĚ ?ʅŐ ŵ> ?ǁĞƌĞ
functionalised to the Ag NP surface and TMB and H2O2 added, little 
TMB oxidation was observed which was evident in the weak CTC 
spectra obtained.  As the concentration of antibody on the surface 
decreased, a more intense CTC spectrum was obtained, indicating 
that more oxidation had occurred.  This was expected as antibodies, 
which are roughly 150 KDa in size, take up a lot of space on the Ag 
NP, significantly reducing the surface area of the Ag metal available 
to partake in the decomposition of H2O2.  This resulted in less TMB 
becoming oxidised and a lower concentration of CTC molecules being 
electrostatically attracted to the surface and experiencing SERRS 
enhancement. The lowest concentration of antibody on the Ag NP 
surface (0.05 ʅŐ ?ŵ> ?gave the most TMB oxidation ĂĨƚĞƌƚŚĞŐEW ?Ɛ; 
however, it was not chosen to be used in the SLISA as the bare Ag NP 
surface could potentially give rise to non-specific binding. Therefore, 
Ag NPs with 0.5 ʅŐ ?ŵ>ŽĨĂŶƚŝďŽĚǇŽŶƚŚĞƐƵƌĨĂĐĞǁere used in the 
subsequent SLISA, since there was enough antibody to detect CRP 
and prevent non-specific binding with sufficient surface area of the 
Ag metal remaining available for TMB oxidation. 
Silver-linked immunosorbent assay 
Ag-Ab NPs were then employed in the SLISA for the detection of CRP, 
replacing the conventional enzyme linked detection antibody.  The 
assay was performed on nitrocellulose coated glass slides encased in 
a microarray chamber to allow separation of samples into individual 
wells.  0.3 µL of 10 µg/mL CRP-specific capture antibody was 
immobilised onto the nitrocellulose coated glass, electrostatically 
attaching them to the surface.  The antibodies were left to incubate 
overnight to allow full immobilisation.  The resulting antibody spots 
were then washed with 0.05 % Tween 20® in PBS (at pH 7.6) three 
times to remove any unbound antibody.  20 µL of CRP was then 
added to each antibody spot and bound to the immobilised 
antibodies.  Further wash steps occurred followed by the addition of 
Ag-Ab NPs which completed the SLISA by binding to the CRP.  The 
assay was then washed, leaving an Ag-Ab NP residue on the spot 
where the capture antibody had originally been deposited.  Finally, 
TMB blotting solution (a solution of premixed TMB and H2O2) was 
added and the immobilised Ag-Ab NPs were able to oxidise the TMB 
in the presence of H2O2.  Upon removal of the TMB blotting solution, 
the positive oxidised TMB was left bound to the Ag surface.  A final 
wash step ensured that only the CTC electrostatically attached to the 
Ag NP surface was left behind.
 
 
The SLISA was performed with varying concentrations of CRP and the 
resulting oxidised TMB was analysed using 633 nm laser excitation.    
Each spot was interrogated at 100 different areas for 9 seconds each 
time to achieve an average CTC spectrum for each concentration of 
CRP added to the SLISA.  The resulting average spectra of oxidised 
TMB obtained for each CRP concentration are shown in Figure 5 (a).   
It can be observed in Figure 5 (a), that the intensity of the oxidised 
CTC decreases as the concentration of CRP is lowered.  This is due to 
there being a lower concentration of Ag-Ab NPs bound to the SLISA 
when there is a lower concentration of CRP to bind to.  The 
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Fig. 4 SERRS spectra of CTC when Ag-Ab NP conjugates (2.5 (dark blue), 
1 (green), 0.5 (pink), 0.25 (blue) and 0.05 (red) and 0 (black) ʅŐ ?ŵ>ŽĨ
antibody) were added to TMB and H2O2.  SERRS spectra were obtained 
using a 638 nm laser excitation with a 1 second accumulation time and 
4.5 mW laser power. The spectra shown are the average of 5 
measurements of 3 replicate samples. 
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appearance of the small extra peaks in the CTC spectrum at 1031, 
1147, 1175 and 1623 cm-1 have been attributed to coming from 
components used in the wash and from the nitrocellulose surface 
itself being enhanced by the Ag NPs; however, they can be 
disregarded as they do not interfere with the overall CTC spectrum.    
The height of the 1610 cm-1 peak was plotted against the logarithm 
to base 10 of the CRP concentration and a satisfying linear 
relationship was observed (over the range of 1.56-25 ng/mL) with a 
correlation coefficient of 0.98 as shown in Figure 5 (b).  The limit of 
detection was calculated using 3 times the standard deviation of the 
blank divided by the gradient of the line and was found to be 1.09 
ng/mL.  The relative standard deviations were calculated using the 
three repeats of each concentration performed in the SLISA and the 
average relative standard deviation of the whole SLISA was 
calculated to be 13.95% indicating good reproducibility of the assay  
The ensure the SLISA was only selective for CRP, control experiments 
were carried out to ensure the response was CRP specific. 25 ng/mL 
of bovine serum albumin (BSA), Human chronic gonadotropin (hCG) 
or CRP was added to immobilised capture antibody, followed by Ab-
Ag NPs and TMB blotting solution.  The SLISA spots were analysed 
and the resulting average SERRS intensity of the 1610 cm-1 of the 
oxidised TMB SERRS spectra obtained for each CRP, BSA and hCG are 
shown in the bar graph in Figure 6 (a). As an oxidised TMB signal was 
only obtained when CRP was present this confirmed the selectivity 
of the SLISA which gave no false positives from interfering 
biomolecules.   
The SLISA was also performed to detect a clinically relevant 
concertation of CRP in serum to demonstrate its potential for the 
detection of clinical samples. 1% SeraSub spiked with 100 ng/mL of 
CRP was added to immobilised capture antibody with 1%  SeraSub 
acting as a blank, followed by Ab-Ag NPs and TMB blotting solution.   
 The SLISA spots were analysed and the resulting average intensity of 
the 1610 cm-1 peak of the oxidised TMB SERRS spectra obtained and 
the results are shown in Figure 6 (b).  TMB was only oxidised when 
CRP was present, therefore CRP could be detected using SLISA in 
ƐĞƌƵŵƐĂŵƉůĞƐĞƋƵĂƚŝŶŐƚŽ ? ?ʅŐ ?ŵ>ŽĨZWŝŶ ? ? ?A?ƐĞƌƵŵ ?ǁŚŝĐŚŝƐ
a clinically relevant concentration which would indicate 
inflammation in the body.24  
Conclusion 
This work reports the first use of the inherent peroxidase-like activity 
of Ag NPs in an ELISA format.  We have shown that Ag-Ab NPs can be 
used to replace antibodies conjugated to conventional  enzymes 
used in an ELISA by catalysing the oxidation of TMB in the presence 
of H2O2.  We have also demonstrated that the SLISA can be analysed 
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Fig. 6 (a) Bar graph of the SERRS intensity of the 1610 cm-1 peak of 
oxidised TMB signal produced from the SLISA performed with CRP, hCG 
and BSA. (b) Bar graph of the intensity of the 1610 cm-1 peak of oxidised 
TMB signal produced from the SLISA performed in 1% serum spiked 
with 100 ng/mL and 1% serum.  Errors bars indicate standard deviation 
from 3 replicates with 100 measurements on each taken. 
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Fig. 5 (a) SERRS response from each SLISA spot obtained when 
different concentrations of CRP were added (25 (black), 12.5 (red), 
6.25 (blue), 3.125 (pink), 1.56 (green) and 0 (dark blue) ng/mL of 
CRP).  SERRS spectra were collected using a 633 nm laser excitation 
with a 9 second accumulation time and 0.8 mW laser power.  (b) Plot 
of  intensity of 1610 cm-1 peak against the Log10 of the CRP 
concentration showing linear relationship in the concentration range 
of 1.56-25 ng/mL (coefficient of determination, R=0.98).  Errors bars 
indicate standard deviation from 3 replicates with 100 
measurements on each taken. 
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using SERRS by utilising the roughened surface of the Ag NPs in 
combination with a laser in resonance with the absorbance maxima 
of the oxidised TMB.  This has allowed for the novel detection of CRP 
with a calculated detection limit of 1.09 ng/mL., which is comparable 
to LODs that have been achieved using fluorescence, 25 
colorimetric,26 and electrochemical detection26 which have reported 
detection limits of between 1-2 ng/mL. The SLISA also showed good 
selectivity and the practicality was demonstrated by detecting CRP in 
a biological matrix.   
Another advantage of the SLISA over the conventional ELISA is the 
decrease in incubation time required for a positive result (20 minute 
incubation of each component as opposed to 2 hours), allowing the 
SLISA to be completed and analysed in a matter of hours instead of a 
whole day.   
Since this method is simply transferrable to almost any target 
analyte, the SLISA has the potential to be applied for the sensitive 
and specific detection of a variety of relevant biomarkers for the 
detection and diagnosis of disease 
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